People · Operator
Named in public records as an officer, director or promoter · active 2025–2025 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cortexyme, Inc. | — | Pharmaceuticals | Series C | $111.5M | $72.0M | 2025 |
Brendan Hannah at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Brendan Hannah on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ilan Zipkin | 1 | 6 |
| Casey Lynch | 1 | 4 |
| Una Ryan | 1 | 4 |
| Charles Ryan | 1 | 3 |
| Dirk Thye | 1 | 3 |
| Roger Quy | 1 | 2 |
| Margi McLoughlin | 1 | 2 |
| David Lamond | 1 | 1 |
| Christopher Senner | 1 | 1 |
| June Bray | 1 | 1 |
| Luca Benatti | 1 | 1 |
| Rajiv Patni | 1 | 1 |
| Stephen A. Dominy | 1 | 1 |
| David A. Lamond | 1 | 1 |
| Ilan A. Zipkin | 1 | 1 |
| Roger A. Quy | 1 | 1 |
| Stephen Dominy | 1 | 1 |
| Margi A. McLoughlin | 1 | 1 |
| Kristen Gafric | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.